Brain Wave Changes During Fenfluramine Treatment in Lennox-Gastaut Syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study tracks how brain wave patterns change when children and young adults with Lennox-Gastaut Syndrome (a severe seizure disorder) take fenfluramine, a medication that helps reduce drop seizures. Researchers will use EEG (brain wave recordings) to understand how this treatment affects the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 2 to 35 years old
- Confirmed diagnosis of Lennox-Gastaut Syndrome with seizure onset by age 11
- Currently taking fenfluramine at the correct dose for at least a few weeks
- At least 2 drop seizures per week (recorded recently)
- Taking 1–4 other seizure medications on a stable dose for at least 30 days
- Brain wave (EEG) recording from within 6 months before starting fenfluramine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a reduced, home-based EEG monitoring device can help doctors safely adjust the dose of fenfluramine, a treatment for seizures in Dravet syndrome and Lennox-Gastaut syndrome. Participation may help find the right dose with fewer hospital visits.
This trial tests a new type of brain stimulation (adaptive deep brain stimulation) that adjusts in real time to stop seizures in children with Lennox-Gastaut syndrome. It's for children who haven't gotten enough help from medications and have frequent drop seizures.
This study tests a brain implant that delivers electrical stimulation during sleep to reduce seizures in people with Lennox-Gastaut syndrome. It aims to improve seizure control and sleep quality.
This study looks at what happens when children with Dravet or Lennox Gastaut syndrome switch from a homemade or artisanal CBD product to Epidiolex, a prescription CBD. The goal is to see if the switch is safe and helps control seizures.
This trial tests the safety of a medicine called fenfluramine for children under 2 years old with Dravet syndrome. It aims to see if fenfluramine can help control seizures in very young children.
This Phase 2 trial studies fenfluramine to treat infantile spasms that haven’t improved after standard medicines (ACTH and vigabatrin). If you/your child has ongoing seizures, the study may offer another treatment option and will monitor safety closely, especially heart-related side effects.
Hear when a new Lennox Gastaut Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.